Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ivo Mueller

Showing results (261-270 of 430) with videos related to

Pageof 43
Sort By:
Antimicrobial Agents and Chemotherapy|August 27, 2014
Plasmodium falciparum and Plasmodium vivax genotypes and efficacy of intermittent preventive treatment in Papua New GuineaCeline Barnadas, Nicolas Senn, Jonah Iga, et al.
Emerging Microbes & Infections|July 6, 2026
Immunodominant B-cell epitopes for precision surveillance of <i>Plasmodium vivax</i> malariaHanqing Zhao, Yinshan Zhu, Jingxian Yin, et al.
Frontiers in Immunology|July 5, 2021
High Antibodies to VAR2CSA in Response to Malaria Infection Are Associated With Improved Birthweight in a Longitudinal Study of Pregnant WomenAlistair R D McLean, D Herbert Opi, Danielle I Stanisic, et al.
Plos Neglected Tropical Diseases|February 16, 2021
Heterogeneity in response to serological exposure markers of recent Plasmodium vivax infections in contrasting epidemiological contextsJason Rosado, Michael T White, Rhea J Longley, et al.
BMC Medicine|May 1, 2018
Human antibodies activate complement against Plasmodium falciparum sporozoites, and are associated with protection against malaria in childrenLiriye Kurtovic, Marije C Behet, Gaoqian Feng, et al.
BMC Infectious Diseases|August 22, 2014
Spatio-temporal epidemiology of the cholera outbreak in Papua New Guinea, 2009-2011Paul F Horwood, Stephan Karl, Ivo Mueller, et al.
Plos One|November 24, 2011
Quantifying the importance of MSP1-19 as a target of growth-inhibitory and protective antibodies against Plasmodium falciparum in humansDanny W Wilson, Freya J I Fowkes, Paul R Gilson, et al.
Medrxiv : the Preprint Server for Health Sciences|June 10, 2025
Understanding <i>Plasmodium vivax</i> recurrent infections using an amplicon deep sequencing assay, PvAmpSeq, identity-by-descent and model-based classificationJason Rosado, Jiru Han, Thomas Obadia, et al.
Antimicrobial Agents and Chemotherapy|August 14, 2019
A Randomized Open-Label Evaluation of the Antimalarial Prophylactic Efficacy of Azithromycin-Piperaquine versus Sulfadoxine-Pyrimethamine in Pregnant Papua New Guinean WomenBrioni R Moore, John M Benjamin, Roselyn Tobe, et al.
Malaria Journal|February 15, 2024
Using serological diagnostics to characterize remaining high-incidence pockets of malaria in forest-fringe CambodiaMathilde Grimée, Costanza Tacoli, Mirco Sandfort, et al.
Pageof 43

Showing results (261-270 of 430) with videos related to

Sort By:
Pageof 43
Antimicrobial Agents and Chemotherapy|August 27, 2014
Plasmodium falciparum and Plasmodium vivax genotypes and efficacy of intermittent preventive treatment in Papua New GuineaCeline Barnadas, Nicolas Senn, Jonah Iga, et al.
Emerging Microbes & Infections|July 6, 2026
Immunodominant B-cell epitopes for precision surveillance of <i>Plasmodium vivax</i> malariaHanqing Zhao, Yinshan Zhu, Jingxian Yin, et al.
Frontiers in Immunology|July 5, 2021
High Antibodies to VAR2CSA in Response to Malaria Infection Are Associated With Improved Birthweight in a Longitudinal Study of Pregnant WomenAlistair R D McLean, D Herbert Opi, Danielle I Stanisic, et al.
Plos Neglected Tropical Diseases|February 16, 2021
Heterogeneity in response to serological exposure markers of recent Plasmodium vivax infections in contrasting epidemiological contextsJason Rosado, Michael T White, Rhea J Longley, et al.
BMC Medicine|May 1, 2018
Human antibodies activate complement against Plasmodium falciparum sporozoites, and are associated with protection against malaria in childrenLiriye Kurtovic, Marije C Behet, Gaoqian Feng, et al.
BMC Infectious Diseases|August 22, 2014
Spatio-temporal epidemiology of the cholera outbreak in Papua New Guinea, 2009-2011Paul F Horwood, Stephan Karl, Ivo Mueller, et al.
Plos One|November 24, 2011
Quantifying the importance of MSP1-19 as a target of growth-inhibitory and protective antibodies against Plasmodium falciparum in humansDanny W Wilson, Freya J I Fowkes, Paul R Gilson, et al.
Medrxiv : the Preprint Server for Health Sciences|June 10, 2025
Understanding <i>Plasmodium vivax</i> recurrent infections using an amplicon deep sequencing assay, PvAmpSeq, identity-by-descent and model-based classificationJason Rosado, Jiru Han, Thomas Obadia, et al.
Antimicrobial Agents and Chemotherapy|August 14, 2019
A Randomized Open-Label Evaluation of the Antimalarial Prophylactic Efficacy of Azithromycin-Piperaquine versus Sulfadoxine-Pyrimethamine in Pregnant Papua New Guinean WomenBrioni R Moore, John M Benjamin, Roselyn Tobe, et al.
Malaria Journal|February 15, 2024
Using serological diagnostics to characterize remaining high-incidence pockets of malaria in forest-fringe CambodiaMathilde Grimée, Costanza Tacoli, Mirco Sandfort, et al.
Pageof 43